The increased frequency of reactivity against Ro52-1 and Ro52-5 in anti-Ro52/anti-Ro60 double positive patients than in anti-Ro52+/anti-Ro60– SSc patients is difficult to explain. Here, TRIM21 is linked to systemic sclerosis.